Recall: Family Wellness Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 Mg Per 1.25 ML
On 2018-12-05, the FDA announced that Tris Pharma is conducting a recall on Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 Mg Per 1.25 ML due to a possible formulation error. The recalled products were sold under the brand name(s) Family Wellness during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 1 drugs recalls due to potential formulation error, including paliperidone extended-release tablets, 3mg, hyoscyamine sulfate 0.125 mg tablets and more. Additionally, there have been 19 drug and medical device recalls due to other health hazards as well as 88 food recalls.
Company Contact Information:
Name: Tris Pharma
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL
Brand Name(s): Family Wellness
Reason for Recall: Formulation Error
Official Recall Date: 2018-12-05
Additional information provided by the FDA.gov:
Pharma, Inc. has voluntarily recalled three (3) lots of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level. The recalled lots of the product have been found to potentially have higher concentrations of ibuprofen. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.